( en | de | ru )

 

Disambiguierung von "Engel, Christoph"

Autor der Publikation

KopierenLöschenDiese Publikation zur Ablage hinzufügen
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers

, , , , , , , , , , , , , , , , , und . Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 (35): 5887–5892 (2009)

Bitte wählen Sie eine Person um die Publikation zuzuordnen

Um zwischen Personen mit demselben Namen zu unterscheiden, wird der akademische Grad und der Titel einer wichtigen Publikation angezeigt. Zudem lassen sich über den Button neben dem Namen einige der Person bereits zugeordnete Publikationen anzeigen.

Christoph Engel

Christoph Engel

Christoph Engel

Christoph Engel

Christoph Engel

 

Weitere Publikationen von Autoren mit dem selben Namen

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk, , , , , , , , , und 252 andere Autor(en). PLoS genetics, 9 (3): e1003212 (2013)Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting BRCA1/2 mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer Consortium, , , , , , , , , und 13 andere Autor(en). Journal of medical genetics, 50 (6): 360–367 (2013)A biomathematical model of human erythropoiesis under erythropoietin and chemotherapy administration, , , und . PloS one, 8 (6): e65630 (2013)Polymorphisms of genes coding for ghrelin and its receptor in relation to colorectal cancer risk: a two-step gene-wide case-control study, , , , , , , , , und 12 andere Autor(en). BMC gastroenterology, (2010)Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2, , , , , , , , , und 172 andere Autor(en). Breast cancer research : BCR, 13 (6): R110 (2011)Variability of structures in German intensive care units--a representative, nationwide analysis, , , , , , und . Wiener klinische Wochenschrift, 122 (19-20): 572–578 (2010)A BRCA1 promoter variant (rs11655505) and breast cancer risk, , , , , , , , , und 8 andere Autor(en). Journal of medical genetics, 47 (4): 268–270 (2010)Absence of association between cyclin D1 (CCND1) G870A polymorphism and age of onset in hereditary nonpolyposis colorectal cancer, , , , , , , , , und 4 andere Autor(en). Cancer letters, 236 (2): 191–197 (2006)Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 German families suspected of hereditary nonpolyposis colorectal cancer, , , , , , , , , und 10 andere Autor(en). International journal of cancer. Journal international du cancer, 116 (5): 692–702 (2005)Association of the BRCA1 missense variant R1699W with a malignant phyllodes tumor of the breast, , , , , , und . Cancer genetics and cytogenetics, 176 (1): 76–79 (2007)